Immunovia
Develops blood tests for early pancreatic cancer detection in high-risk individuals.
IMMNOV | ST
Overview
Corporate Details
- ISIN(s):
- SE0006091997 (+2 more)
- LEI:
- 549300KHWL6KK1XGUO81
- Country:
- Sweden
- Address:
- Scheelevägen 8, 223 63 LUND
- Website:
- https://immunovia.com/
- Sector:
- Human health and social work activities
- Industry:
- Other human health activities
Description
Immunovia is a diagnostics company dedicated to revolutionizing the early detection of pancreatic cancer to improve patient survival rates. The company's primary product is the PancreaSure™ test, a simple, blood-based assay designed to identify biomarkers associated with pancreatic cancer in its early, more treatable stages (1 and 2). The test is specifically targeted at individuals at high risk for the disease due to family history or genetic mutations, offering a convenient and accurate method for annual surveillance. By focusing on early detection, Immunovia addresses a critical unmet need in oncology, aiming to provide a diagnostic tool that can significantly enhance patient outcomes for one of the deadliest forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-03 15:00 |
Share Issue/Capital Change
Immunovia publishes information document regarding rights issue
|
English | 69.2 KB | ||
| 2025-10-03 15:00 |
Share Issue/Capital Change
Immunovia offentliggör informationsdokument avseende företrädesemission
|
Swedish | 67.6 KB | ||
| 2025-09-29 14:15 |
Post-Annual General Meeting Information
Kommuniké från extra bolagsstämma i Immunovia AB (publ)
|
Swedish | 44.9 KB | ||
| 2025-09-29 14:15 |
Post-Annual General Meeting Information
Bulletin from the extraordinary general meeting in Immunovia AB (publ)
|
English | 44.4 KB | ||
| 2025-09-25 20:50 |
Share Issue/Capital Change
Immunovia announces final terms of rights issue
|
English | 78.2 KB | ||
| 2025-09-25 20:50 |
Share Issue/Capital Change
Immunovia offentliggör slutliga villkor i företrädesemission
|
Swedish | 76.6 KB | ||
| 2025-09-08 08:00 |
Share Issue/Capital Change
Immunovia enters into top guarantee commitments for the upcoming rights issue
|
English | 64.5 KB | ||
| 2025-09-08 08:00 |
Share Issue/Capital Change
Immunovia ingår toppgarantiåtaganden för den kommande företrädesemissionen
|
Swedish | 64.4 KB | ||
| 2025-08-28 08:30 |
Interim Report
|
Swedish | 2.7 MB | ||
| 2025-08-28 08:30 |
Interim Report
|
English | 2.7 MB | ||
| 2025-08-27 18:00 |
Pre-Annual General Meeting Information
NOTICE OF EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)
|
English | 65.2 KB | ||
| 2025-08-27 18:00 |
Pre-Annual General Meeting Information
KALLELSE TILL EXTRA BOLAGSSTÄMMA I IMMUNOVIA AB (PUBL)
|
Swedish | 64.7 KB | ||
| 2025-08-27 17:45 |
Share Issue/Capital Change
Immunovia genomför en företrädesemission om cirka 100 MSEK och säkrar brygglån
|
Swedish | 87.4 KB | ||
| 2025-08-27 17:45 |
Share Issue/Capital Change
Immunovia carries out a rights issue of approximately SEK 100 million and secur…
|
English | 86.9 KB | ||
| 2025-07-28 10:10 |
Major Shareholding Notification
|
Swedish | 10.5 KB |
Automate Your Workflow. Get a real-time feed of all Immunovia filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Immunovia via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-03 | michael Lofman | Other | Sell | 587,532 | 1,292,570.40 SEK |
| 2023-06-07 | Jeffrey Borcherding | Other | Buy | 350,000 | 61,810.00 USD |
| 2023-04-06 | Hans Johansson | Other | Buy | 14,924 | 99,990.80 SEK |
| 2023-03-28 | Martin Moeller | Other | Other | 1,408 | 9,433.60 SEK |
| 2022-11-15 | Philipp Mathieu | Other | Buy | 150,000 | 297,000.00 SEK |
| 2022-05-24 | Jeffrey Borcherding | Other | Buy | 100,000 | 150,000.00 SEK |
| 2022-02-22 | Peter Andersen | Other | Buy | 6,000 | 186,000.00 SEK |
| 2021-09-02 | Martin Moeller | Other | Buy | 1,056 | 141,292.80 SEK |
| 2021-05-28 | Patrik Dahlen | Other | Buy | 6,860 | 675,984.40 SEK |
| 2021-05-07 | Peter Andersen | Other | Buy | 2,730 | 297,570.00 SEK |
